Fitch Ratings downgraded the long- and short-term issuer default ratings of Wells Fargo & Company to A+/F1 from AA-/F1+. Fitch also downgraded the LT IDR of Wells Fargo Bank to AA-.
Wells Fargo Capital Finance announced it acted as sole lead arranger and bookrunner on a $55 million revolver to be used for working capital and general corporate purposes for Evergreen Enterprises.
Wells Fargo Capital Finance announced that Michael Janda joined as managing director of its Healthcare Finance team. He previously served in a primary role at a home health company as founder and president of Citra Associates.